Refractory vertebral basilar artery dissection
Conditions
Interventions
Control group:one-stage procedure
Experimental group:Staging procedure
Sponsors
The First Affiliated Hospital of Naval Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Aged 18 to 80 years old, male or non-pregnant female; 2. A refractory VBD diagnosed by MRA or CTA for symptomatic VBD; 3. Expected survival >=3 months; 4. The function of the main organs is normal; 5. The subjects are willing to participate in the study, sign the informed consent, have good compliance, and cooperate with the follow-up.
Exclusion criteria
Exclusion criteria: 1. Patients without proper vascular approach; 2. Patients with prior serious cardiovascular disease; 3. Patients with abnormal coagulation function and bleeding tendency; 4. Those who are not considered suitable for inclusion by researchers; 5. Pregnant and lactating women; 6. Ruptured and conservatively treated refractory VBD; 7. Patients who cannot receive antiplatelet aggregation or anticoagulant therapy; 8. Today contrast agent allergy or can not tolerate the patient; 9. Those who had participated in clinical trials of other drugs or medical devices before being included in the study and failed to reach the time limit of the main study endpoint; 10. The attending researchers deem it inappropriate to participate in or continue to participate in this clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Prognosis; | — |
Secondary
| Measure | Time frame |
|---|---|
| Angiographic follow-up; | — |
Countries
China
Contacts
Public ContactKai-Jun Zhao
The First Affiliated Hospital of Naval Medical University
Outcome results
None listed